* IN THE HIGH COURT OF DELHI AT NEW DELHI % Judgment delivered on: 28.03.2026 + CS(COMM) 39/2023 SUN PHARMA LABORATORIES LIMITED .....Plaintiff versus INTAS PHARMACEUTICALS LIMITED .....Defendant Advocates who appeared in this case For the Plaintiff : Mr. Sachin Gupta, Ms. Mahima Chanchalani, Ms. Prashansa, Mr. Rohit Pradhan, Ms. Diksha, Mr. Ajay & Mr.

Aadarsh, Advocates.

For the Defendant : Ms. Bitika Sharma, Mr. George Vithayathil, Ms. Ahaana Singh Rana & Mr. Aditya P.

Mishra, Advocates.

CORAM:

HON'BLE MR. JUSTICE TEJAS KARIA

JUDGMENT

TEJAS KARIA, J

1. The present Suit has been filed seeking a permanent injunction against infringement of the Trade Mark ‘BEVETEX’ (“Plaintiff’s Mark”), passing off, unfair competition, dilution, rendition of accounts and damages.

2. The drug under the Plaintiff’s Mark (“Plaintiff’s Drug”) is a scheduled drug used for treatment of breast cancer, non-small cell lung cancer and pancreatic cancer. The Defendant is using the Mark ‘BEVATAS’

(“Impugned Mark”) for manufacturing and selling drugs for treatment of colorectal cancer, ovarian cancer, cervical cancer, lung cancer and recurrent glioblastoma (“Defendant’s Drug”).

PROCEDURALHISTORY:

3. The present Suit was l